Serology for trachoma surveillance after cessation of mass drug administration.

• Main Authors: Diana L Martin (Author), Rhiannon Bid (Author), Frank Sandi (Author), E Brook Goodhew (Author), Patrick A Massae (Author), Augustin Lasway (Author), Heiko Philippin (Author), William Makupa (Author), Sandra Molina (Author), Martin J Holland (Author), David C W Mabey (Author), Chris Drakeley (Author), Patrick J Lammie (Author), Anthony W Solomon (Author)
• Format: Book
• Published: Public Library of Science (PLoS), 2015-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

BACKGROUND:Trachoma, caused by Chlamydia trachomatis (Ct), is the leading infectious cause of blindness worldwide. Yearly azithromycin mass drug administration (MDA) plays a central role in efforts to eliminate blinding trachoma as a public health problem. Programmatic decision-making is currently b...